Article
Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda.
Archives of dermatology - 1 Mar 2003
Stölzel Ulrich, Köstler Erich, Schuppan Detlef, Richter Matthias, Wollina Uwe, Doss Manfred O, Wittekind Christian, Tannapfel Andrea
Abstract excerpt
OBJECTIVE: To examine the role of hemochromatosis (HFE) gene mutations, which are associated with porphyria cutanea tarda (PCT), in the therapeutic response to chloroquine. DESIGN: We retrospectively analyzed a database (Excel version 2001 [Microsoft Excel, Redmond, Wash]; date range of search, 1985-1999) of chloroquine-treated patients with PCT on whether HFE mutations (C282Y and H63D) might have influenced the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
